# VERQIA — Public Launch Readiness 2026 — Progress register

**Last updated:** 8 November 2026  
**Operating rule:** a row can be `VERIFIED` only when its cited evidence was actually executed or inspected. A green build is not evidence that an unconfigured public service is operational.

## Permitted status values

`NOT_STARTED` · `IN_PROGRESS` · `BLOCKED` · `NEEDS_USER_VALIDATION` · `VERIFIED` · `NOT_APPLICABLE`

## Programme register

| ID | Phase | Status | Files / action | Method | Result | Evidence |
|---|---|---|---|---|---|---|
| PRG-00 | Programme | `IN_PROGRESS` | Full 2026 readiness programme | Evidence-led audit before material changes | Audit documented; public launch is not authorized or executed | `PHASE-0-AUDIT.md`, `VERQIA-PUBLIC-LAUNCH-READINESS-REPORT.md` |
| P0-01 | 0 | `VERIFIED` | Repository architecture, routes, services and environment | Static inventory of `app/`, `components/`, `lib/`, `config/`, package scripts and deployment files | Localized Next.js presentation frontend; no API route, database schema or server-side product service found | `PHASE-0-AUDIT.md` §§2–4 |
| P0-02 | 0 | `VERIFIED` | TypeScript, lint and unit suites | `npm run typecheck`; `npm run lint`; `npm test` | Typecheck and lint completed; Vitest reported 5 files / 16 tests | `PHASE-0-TEST-EVIDENCE.md` §1 |
| P0-03 | 0 | `VERIFIED` | Production build and publication safeguards | `NEXT_PUBLIC_SCROLL_PRESET=balanced npm run build` | Optimized build completed; 50 generated pages; indexation remained disabled | `PHASE-0-TEST-EVIDENCE.md` §2 |
| P0-04 | 0 | `VERIFIED` | Dependency vulnerability audit | `npm audit --omit=dev --json` and full `npm audit --json` | 0 reported vulnerabilities; full dependency metadata recorded | `PHASE-0-TEST-EVIDENCE.md` §3 |
| P0-05 | 0 | `VERIFIED` | Browser navigation E2E in production mode | Built app served locally with `next start`; existing 3 Playwright scenarios executed through a temporary external audit config | Desktop keyboard menu, mobile focus trap and locale/legal-footer scenarios passed: 3/3 | `PHASE-0-TEST-EVIDENCE.md` §4 |
| P0-06 | 0 | `VERIFIED` | Repository-native Playwright execution against production artifact | `npm run test:e2e` now builds first; Playwright starts only `next start` | Repeatable local run completed: 9/9 tests passed, including reduced-motion hydration, theme-script handling and responsive V/VERQIA brand checks. This is local artifact evidence, not CI/staging evidence. | `PHASE-0-TEST-EVIDENCE.md` §12; decision D-021 |
| P0-07 | 0 | `VERIFIED` | Public route smoke scan | Fresh Playwright page context per 22 public paths × FR/EN against current local production server | 44/44 public route-locales returned 200 without page errors; production `/_kit` returned 404 in both locales | `PHASE-0-TEST-EVIDENCE.md` §13 |
| P0-08 | 0 | `VERIFIED` | Baseline accessibility and responsive heuristics | Fresh DOM checks across 44 public route-locales at 390px and 1440px | No stated structural issue or horizontal overflow found; explicit limitation: no WCAG conformance claim | `PHASE-0-TEST-EVIDENCE.md` §13; `PHASE-4-LOCAL-TECHNICAL-EVIDENCE.md` |
| P0-09 | 0 | `VERIFIED` | Internal kit hydration regression and exposure | Hydration-safe state applied; production proxy test requests `/{fr,en}/_kit` | The public production route returns HTTP 404 in both locales; internal development route is retained | `PHASE-0-TEST-EVIDENCE.md` §12–13; decision D-023 |
| P0-10 | 0 | `VERIFIED` | Local security/indexing baseline | Source review plus headers, `robots.txt`, sitemap and metadata on current local production app | Generic application headers verified; no API route; production audit reports 0 runtime vulnerabilities; `noindex,nofollow` remains emitted while robots allows crawling | `PHASE-0-TEST-EVIDENCE.md` §14; `PHASE-4-LOCAL-TECHNICAL-EVIDENCE.md` |
| P0-11 | 0 | `NEEDS_USER_VALIDATION` | Actual deployment, DNS, TLS, hosting account, logs and external services | No authorized production/staging URL or service credentials supplied | Cannot verify real headers, TLS, domain ownership, DPA, email delivery, Supabase, RLS, monitoring, backups or restore | `PHASE-0-AUDIT.md` §8 |
| P0-12 | 0 | `VERIFIED` | Risk register and intervention plan | Consolidated executed evidence and source review | 13 launch risks and ordered interventions recorded; no GO recommendation | `PHASE-0-AUDIT.md` §§9–10 |
| P1-01 | 1 | `NEEDS_USER_VALIDATION` | Legal entity, registration, tax, capital, representative and publication director | Founder must supply approved public information | No values will be invented | `USER_VALIDATIONS.md` UV-01 |
| P1-02 | 1 | `NEEDS_USER_VALIDATION` | Official domain, contact and hosting information | Founder must confirm ownership and authorized public channels | Current local configuration has no public contact or domain | `USER_VALIDATIONS.md` UV-02; risk R-002 |
| P1-03 | 1 | `IN_PROGRESS` | Legal texts, privacy, cookies and Côte d’Ivoire/ARTCI review | User reports review in progress; counsel/authorized reviewer must assess actual processing and publication | Templates and references exist; no reviewer identity, scope, date or professional approval evidence is available | `USER_VALIDATIONS.md` VR-004; `PHASE-1-INSTITUTIONAL-LEGAL.md` |
| P1-04 | 1 | `NOT_STARTED` | Deployment-specific cookie inventory and notice validation | Requires a deployed staging environment and approved service list | No deployed environment authorized for inspection | `PHASE-1-INSTITUTIONAL-LEGAL.md` |
| P2-01 | 2 | `NOT_APPLICABLE` | Real contact / quote / demonstration request flow for this first release | UV-04/VR-004 requires no form, solicitation CTA or external channel; current page exposes no public channel | A future flow remains separately blocked until receiver, anti-abuse, retention and end-to-end proof exist | `PHASE-2-COMMERCIAL-VALIDATION-REGISTER.md`; decision D-017 |
| P2-02 | 2 | `NEEDS_USER_VALIDATION` | Offer, pilot, pricing, testimonials, partners and public claims | Founder must approve factual commercial content and evidence | Indicative content is labelled; no client/partner/testimonial claim will be created | `USER_VALIDATIONS.md` UV-04 |
| P2-03 | 2 | `NOT_STARTED` | Abuse controls and lead-data retention | Depends on approved intake channel and legal data rules | Cannot design a real lead pipeline without a chosen processor/owner | `PHASE-2-COMMERCIAL.md` |
| P3-01 | 3 | `VERIFIED` | Product truth matrix | Source and rendered-content review | Product routes are presentation/concept demonstrations; no operational product backend found | `PHASE-3-PRODUCT.md` |
| P3-02 | 3 | `NOT_APPLICABLE` | Real authentication and authorization for the first public informational release | User selected informational/conceptual scope; Supabase/provider/RLS are absent and must not be activated or claimed | Current UI correctly says authentication is unavailable; operational auth remains a future separately-authorized scope | `USER_VALIDATIONS.md` VR-002; `PHASE-3-PRODUCT.md`; risk R-004 |
| P3-03 | 3 | `NOT_APPLICABLE` | Tenant isolation, roles and business-data workflows for the first public informational release | Requires an authorized backend and non-personal test dataset, which is outside selected scope | No database or server authorization layer exists; no product-data workflow will be claimed | `USER_VALIDATIONS.md` VR-002; `PHASE-3-PRODUCT.md` |
| P4-01 | 4 | `VERIFIED` | Source quality and dependency baseline | Executed quality/audit commands | Typecheck, lint, unit tests, build and npm audit evidence recorded | `PHASE-0-TEST-EVIDENCE.md` §§1–3 |
| P4-02 | 4 | `IN_PROGRESS` | Security hardening plan | Generic headers added to `next.config.ts` and inspected from local production artifact | MIME/referrer/frame/permissions/opener headers present locally; CSP/HSTS/TLS require authorized HTTPS staging and service inventory | `PHASE-4-LOCAL-TECHNICAL-EVIDENCE.md`; risk R-005 |
| P4-03 | 4 | `NOT_STARTED` | Accessibility conformance audit | Heuristic scan completed; full keyboard, screen-reader and automated WCAG audit remains | No target WCAG level or audited staging URL has been supplied | `PHASE-4-TECHNICAL.md`; risk R-010 |
| P4-04 | 4 | `IN_PROGRESS` | Performance baseline and representative performance plan | Local fresh-navigation timings sampled on eight representative FR/EN routes | Local baseline captured only; no budget, staging, RUM or Core Web Vitals evidence exists | `PHASE-4-LOCAL-TECHNICAL-EVIDENCE.md`; risk R-012 |
| P4-05 | 4 | `NOT_STARTED` | Monitoring, alerting, logging, backup and restore | No operational platform configuration or data store has been supplied | Cannot execute a restore drill or validate alerts | `PHASE-4-TECHNICAL.md`; risk R-006 |
| P5-01 | 5 | `BLOCKED` | Separate staging and controlled deployment path | No staging domain/account/CI workflow documented | `vercel.json` names only region `cpt1`; it is not a deployment/rollback procedure | `PHASE-5-PREPRODUCTION-LAUNCH.md`; risk R-006 |
| P5-02 | 5 | `VERIFIED` | Desktop/mobile E2E local baseline | Repository-native command builds then tests the current production artifact | 9/9 current Playwright tests passed, including reduced-motion hydration, theme-script handling and responsive V/VERQIA brand checks; staging acceptance remains a separate blocked gate | `PHASE-0-TEST-EVIDENCE.md` §12; `tests/e2e/informational-scope.spec.ts` |
| P5-03 | 5 | `NOT_STARTED` | Launch, rollback, incident and communications checklist | Requires approved hosting, domain, owner and service integrations | No publication is scheduled or authorized | `PHASE-5-PREPRODUCTION-LAUNCH.md` |
| P5-04 | 5 | `NOT_STARTED` | Final GO / NO-GO | Gates are intentionally unmet | Current recommendation remains NO-GO | `VERQIA-PUBLIC-LAUNCH-READINESS-REPORT.md` |

## Controlled-continuation evidence — 8 November 2026

The following controlled changes were made after the initial evidence capture and were validated locally: scope gates for public auth/contact/commercial claims; no public Offer schema; production 404 protection for `/_kit`; reproducible artifact E2E; and generic application security headers. They do not close UV-01, UV-02, UV-03, UV-04, UV-05, UV-08 or UV-09, and do not authorize deployment.

Supporting records: `CURRENT-STATE-2026-11-08.md`, `PHASE-1-LEGAL-REVIEW-PACKET.md`, `PHASE-2-COMMERCIAL-VALIDATION-REGISTER.md`, `PHASE-4-LOCAL-TECHNICAL-EVIDENCE.md`, and `PHASE-5-PREPRODUCTION-EVIDENCE-PLAN.md`.

## Evidence naming convention

Evidence files describe the command, inspection method, scope, outcome and known limits. They do not contain secrets, production credentials or personal test data.
